Linsheng Zhang, MD, PhD
-
RolePathology
-
Research Program
-
Practicing Since2011
Background
Linsheng Zhang, MD, PhD is Associate Professor in the Department of Pathology & Laboratory Medicine at Emory University School of Medicine. Dr. Zhang's specializes in diagnostic hematopathology integrating morphologic examination, flow cytometric immunophenotyping, cytogenetics, FISH, and microarray studies; and molecular diagnosis of solid tumors. He serves as an attending physician on the Hematopathology and Molecular Diagnostic Laboratory service at Emory University Hospital.
Dr. Zhang received his MD from Third Military Medical University in Chongqing, China in 1986 and his PhD from Institute of Hematology at Beijing Medical University in China in 1995. He completed his Residency in Anatomic and Clinical Pathology from the Medical University of South Carolina in 2011. At Emory University, Dr. Zhang completed fellowships in hematopathology and molecular genetic pathology in 2012 and 2013 respectively.
Dr. Zhang's research interest is in the genetic profiling of hematologic malignancies including myeloid neoplasms, lymphomas, multiple myeloma, and solid tumors, especially lung cancer and melanoma, using high resolution microarray, RNA-seq, and panel gene sequencing, aiming at bringing these into clinical laboratory as routine diagnostic tests.
PubMed
Titles & Roles
-
Associate Professor, Department of Pathology and Laboratory MedicineEmory University School of Medicine
Education & Training
Education
- Fellowship, Molecular Genetic Pathology, 2013Emory University School of Medicine
- Fellowship, Hematology, 2012Emory University School of Medicine
- Residency, Pathology-Anatomic, 2011Medical University of South Carolina
- Fellowship, , 2003Uniformed Services Univ of Hlth Sciences
- Medical Education, , 1986Third Military Medical University, China
Board Certifications
- Molecular Genetic PathologyAmerican Board of Pathology, 2013HematologyAmerican Board of Pathology, 2012Clinical PathologyAmerican Board of Pathology, 2011Anatomic PathologyAmerican Board of Pathology, 2011
Title/Journal Authors Publication Date Cancers
L Zhang, G Deeb, KK Deeb, C Vale, D Peker Barclift, N Papadantonakis 15/04/2024 Archives of pathology & laboratory medicine
S Bidot, J Yin, P Zhou, L Zhang, KK Deeb, G Smith, CE Hill, J Xiu, MA Bilen, KB Case, M Tinsley, B Carthon, LR Harik 01/03/2024 Cancers
T Verma, N Papadantonakis, D Peker Barclift, L Zhang 25/01/2024 Bilateral breast Rosai-Dorfman disease screen detected by mammography.
Clinical case reports
C Sumner, K Salem, L Abunimer, A Ewaz, L Zhang, A Monsrud, N Calisi 01/03/2023 Laboratory medicine
OC Puglianini, D Peker, L Zhang, N Papadantonakis 05/01/2023 International journal of laboratory hematology
Y Ding, GH Smith, K Deeb, T Schneider, A Campbell, L Zhang 01/10/2022 Comment on "A Novel COL1A1-CAMTA1 Rearrangement in Cranial Fasciitis".
International journal of surgical pathology
KK Deeb, S Li, L Zhang 01/10/2022 Update on the Classification of and Diagnostic Approaches to Mature T-Cell Lymphomas.
Archives of pathology & laboratory medicine
X Zhang, J Zhou, X Han, E Wang, L Zhang 01/08/2022 Stable flow-induced expression of KLK10 inhibits endothelial inflammation and atherosclerosis.
eLife
D Williams, M Mahmoud, R Liu, A Andueza, S Kumar, DW Kang, J Zhang, I Tamargo, N Villa-Roel, KI Baek, H Lee, Y An, L Zhang, EW Tate, P Bagchi, J Pohl, LO Mosnier, EP Diamandis, K Mihara, MD Hollenberg, Z Dai, H Jo 11/01/2022 Diagnostic cytopathology
AE Mindiola-Romero, X Liu, JL Dillon, M Talarico, G Smith, L Zhang, K Linos 01/03/2021 Journal of cutaneous pathology
Z Evangelou, L Zhang, LJ Tafe, L Azzouz, Z Grada, K Linos 01/02/2021 Mantle Cell Lymphoma With Mantle Zone Growth Pattern.
American journal of clinical pathology
J Yuan, S Li, X Liu, RJ Su, M Chen, X Wu, G Zheng, LM Smith, L Wang, Y Li, C Liu, J Zhou, Q Shen, L Zhang, E Wang, ML Xu, Z Pan 05/07/2019 Journal of cutaneous pathology
N Olson, O Rouhi, L Zhang, C Angeles, J Bridge, D Lopez-Terrada, T Royce, K Linos 01/12/2018 EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors.
The oncologist
F Vargas-Madueno, E Gould, R Valor, N Ngo, L Zhang, MA Villalona-Calero 01/10/2018 The Journal of molecular diagnostics : JMD
T Schneider, GH Smith, MR Rossi, CE Hill, L Zhang 01/05/2018 Multimodality Technologies in the Assessment of Hematolymphoid Neoplasms.
Archives of pathology & laboratory medicine
S Li, DL Jaye, KT Bradley, L Zhang, D Saxe, G Deeb, CE Hill, KP Mann 01/03/2017 The Journal of molecular diagnostics : JMD
KD Davies, MS Farooqi, M Gruidl, CE Hill, J Woolworth-Hirschhorn, H Jones, KL Jones, A Magliocco, M Mitui, PH O'Neill, R O'Rourke, NM Patel, D Qin, E Ramos, MR Rossi, TM Schneider, GH Smith, L Zhang, JY Park, DL Aisner 01/07/2016 The Journal of molecular diagnostics : JMD
KE Fisher, L Zhang, J Wang, GH Smith, S Newman, TM Schneider, RN Pillai, RR Kudchadkar, TK Owonikoko, SS Ramalingam, DH Lawson, KA Delman, BF El-Rayes, MM Wilson, HC Sullivan, AS Morrison, S Balci, NV Adsay, AA Gal, GL Sica, DF Saxe, KP Mann, CE Hill, FR Khuri, MR Rossi 01/03/2016 Leukemia & lymphoma
L Zhang, RT Ramjit, CE Hill, M Arellano, HJ Khoury, KP Mann 01/02/2016 Development and validation of CALR mutation testing for clinical diagnosis.
American journal of clinical pathology
CL Maier, KE Fisher, HH Jones, CE Hill, KP Mann, L Zhang 01/11/2015 International journal of clinical and experimental pathology
CB Duckworth, L Zhang, S Li 01/01/2014 Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.